Literature DB >> 15548393

Risk factors and obstetric complications associated with macrosomia.

N E Stotland1, A B Caughey, E M Breed, G J Escobar.   

Abstract

OBJECTIVE: Macrosomia is associated with adverse maternal outcomes. The objective of this study was to characterize the epidemiology of macrosomia and related maternal complications.
METHOD: Live births (146,526) were identified between 1995 and 1999 in the Kaiser Permanente Medical Care Program's Northern California Region (KPMCP NCR) database. Bivariate and multivariate analyses were performed for risk factors and complications associated with macrosomia (birth weight >4500 g). RESULT: Male infant sex, multiparity, maternal age 30-40, white race, diabetes, and gestational age >41 weeks were associated with macrosomia (p<0.001). In bivariate and multivariate analyses, macrosomia was associated with higher rates of cesarean birth, chorioamnionitis, shoulder dystocia, fourth-degree perineal lacerations, postpartum hemorrhage, and prolonged hospital stay (p<0.01).
CONCLUSION: Macrosomia was associated with adverse maternal outcomes in this cohort. More research is needed to determine how to prevent complications related to excessive birth weight.

Entities:  

Mesh:

Year:  2004        PMID: 15548393     DOI: 10.1016/j.ijgo.2004.08.010

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  57 in total

1.  Are the neonatal outcomes similar in large-for-gestational age infants delivered by women with or without gestational diabetes mellitus?

Authors:  Esra E Onal; Ibrahim M Hirfanoglu; Serdar Beken; Nilgun Altuntas; Canan Turkyilmaz; Aysu Duyan Camurdan; Ozden Turan; Ebru Ergenekon; Esin Koc; Yildiz Atalay
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Preventive induction of labor: potential benefits if proved effective.

Authors:  Aaron B Caughey
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

3.  Health care utilization in the first year of life among small- and large- for-gestational age term infants.

Authors:  Patricia M Dietz; Joanne H Rizzo; Lucinda J England; William M Callaghan; Kimberly K Vesco; F Carol Bruce; Joanna E Bulkley; Andrea J Sharma; Mark C Hornbrook
Journal:  Matern Child Health J       Date:  2013-08

4.  Prepregnancy Obesity and Birth Outcomes.

Authors:  Susan L Averett; Erin K Fletcher
Journal:  Matern Child Health J       Date:  2016-03

5.  Pre-pregnant body mass index, weight gain and the risk of delivering large babies among non-diabetic mothers.

Authors:  C Kabali; M M Werler
Journal:  Int J Gynaecol Obstet       Date:  2007-03-21       Impact factor: 3.561

6.  Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age.

Authors:  Valérie Gagné-Ouellet; Andrée-Anne Houde; Simon-Pierre Guay; Patrice Perron; Daniel Gaudet; Renée Guérin; Baillargeon Jean-Patrice; Marie-France Hivert; Diane Brisson; Luigi Bouchard
Journal:  Epigenetics       Date:  2017-05-09       Impact factor: 4.528

7.  Impact of aspirin on fetal growth in diabetic pregnancies according to White classification.

Authors:  Katlynn Adkins; Amanda A Allshouse; Torri D Metz; Kent D Heyborne
Journal:  Am J Obstet Gynecol       Date:  2017-06-30       Impact factor: 8.661

8.  Supplemental iron intake and the risk of glucose intolerance in pregnancy: re-analysis of a randomised controlled trial in Finland.

Authors:  Tarja I Kinnunen; Riitta Luoto; Annika Helin; Elina Hemminki
Journal:  Matern Child Nutr       Date:  2014-07-04       Impact factor: 3.092

9.  The relationship between maternal and fetal vitamin D, insulin resistance, and fetal growth.

Authors:  Jennifer M Walsh; Ciara A McGowan; Mark Kilbane; Malachi J McKenna; Fionnuala M McAuliffe
Journal:  Reprod Sci       Date:  2012-09-11       Impact factor: 3.060

10.  Risk Factors for Macrosomia.

Authors:  Elie Nkwabong; Guilherme Roger Nzalli Tangho
Journal:  J Obstet Gynaecol India       Date:  2014-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.